10. S畛 ph但n 畛nh TSG nh畉 v TSG n畉ng c坦 th畛 SAI
v狸 c叩c tri畛u ch畛ng TSG nh畉 c坦 th畛 di畛n ti畉n
nhanh ch坦ng sang TSG n畉ng
Williams Obstetrics, 23rd edition, 2010
11. 叩nh gi叩 l但m sng tr棚n thai ph畛
Quy畉t 畛nh l但m sng trong qu畉n l箪 ti畛n s畉n
gi畉t
12 24 38
TSG kh畛i ph叩t s畛m TSG kh畛i ph叩t
mu畛n
Tu畛i thai / tu畉n
K辿o di tu畛i thai khi c坦 th畛1
D畛 ph嘆ng cho ph畛
n畛 c坦 nguy c董 2
34 37208
1st prenatal appointment:
assessment of risks
Khuy畉n c叩o sanh1
Nhi畛u Trung b狸nh 鱈tNguy c董 c畛a m畉 1
12 week
scan
20 week
scan
1 Steegers EAP et al. Lancet 2010;376:63144
2 Hypertension in pregnancy: the management of hypertensive disorders during pregnancy, 2011, NICE guidelines
12. 1st trimester
screening
(all pregnancies)
High risk
Aspirin treatment
Close monitoring
Follow-up in 2nd
trimester
Follow-up in 3rd
trimester
Referral to
specialists
Low risk
Follow-up in 2nd
trimester
Follow-up in 3rd
trimester
D畛 ph嘆ng c畉p 1 l b動畛c h畛 tr畛 cho
d畛 ph嘆ng c畉p 2, c畉p 3
D畛 ph嘆ng c畉p 1 l b動畛c h畛 tr畛 cho d畛 ph嘆ng c畉p 2 nh畉m x叩c 畛nh
nh坦m thai ph畛 c坦 nguy c董 cao c畉n theo d探i v chm s坦c k畛 h董n
D畛 ph嘆ng c畉p 2, c畉p 3 l m畛t giai o畉n 畛c l畉p v畛i k畉t qu畉 d畛
ph嘆ng c畉p 1 v 動畛c th畛c hi畛n 畛c l畉p b畉t c畛 khi no thai ph畛
b畛 nghi ng畛 TSG.
sFlt-1/PlGF ratio
13. Ch畉n o叩n v ph但n t畉ng nguy c董 TSG 達 動畛c
c畉i thi畛n v畛i x辿t nghi畛m sFlt-1/PIGF
Mang 畉n nhi畛u l畛i 鱈ch v畛 kinh t畉 y t畉
cho thai ph畛
14. Qu畉n l箪 b畛nh nh但n Ti畛n s畉n gi畉t
Ch畉n o叩n d畛a tr棚n c叩c tri畛u ch畛ng kh担ng
畉c hi畛u s畉 kh担ng 畛 ch鱈nh x叩c
TSG l nguy棚n nh但n hng 畉u d畉n 畉n b畛nh su畉t v t畛
su畉t m畉 v b辿 tr棚n Th畉 gi畛i 1
Protein ni畛u kh担ng ch鱈nh x叩c v bi畉n ch畛ng TSG c坦 th畛 x畉y ra
tr動畛c khi xu畉t hi畛n protein ni畛u1
Theo nh畛ng guidelines t畛 2013 達 c畉p nh畉t v h畛 tr畛 cho ch畉n o叩n
Ti畛n s畉n gi畉t d畛a tr棚n CHA v c叩c tri畛u ch畛ng kh叩c do r畛i lo畉n
ch畛c nng c叩c c董 quan c畛a m畉 (bao g畛m ACOG2, ISSHP3)
Ch畉n o叩n l但m sng d畛a vo CHA v
protein ni畛u1
1. Stepan, H., et al. (2015). Ultrasound Obstet Gynecol 45, 241-246
2. ACOG Task Force on Hypertension in Pregnancy (2013). Obst & Gynecol 122,1122-1131
3. Tranquilli, A.L., et al. (2014). Pregnancy Hypertens 4, 97104
ISSHP: International society for the study of hypertension in pregnancy; ACOG: American college of obstetricians and gynecologists
15. Cut-offs sFlt-1/PlGF 畉c hi畛u theo tu畛i thai
ti棚n l動畛ng ng畉n h畉n v ch畉n o叩n TSG
1. Zeisler, H., et al. (2016).N Engl J Med 374(1), 13-22
2. Verlohren et al (2014). Hypertension 63, 346-352
85 11038
Kh畛i
ph叩t
s畛m
Tu畛i thai
(Tu畉n)
20
34
Kh畛i
ph叩t
mu畛n
sFlt-1/PlGF ratio
38
BN s畉 kh担ng
ph叩t tri畛n TSG
trong 1 tu畉n1
85
38
> 38 -
< 85
H畛 tr畛 ch畉n o叩n*
110
TSG v c叩c r畛i lo畉n
li棚n quan 畉n nhau
thai2
Bn s畉 ph叩t tri畛n TSG trong 4
tu畉n
> 38 -
< 110
Ti棚n l動畛ng ng畉n h畉n*
*Used in addition to other accepted diagnostic tools and clinical information
cut-off 畉c hi畛u theo tu畛i thai
17. Cut-off 38 gi炭p x叩c 畛nh TSG
trong 4 tu畉n t畉p trung 炭ng thai
ph畛 c畉n chm s坦c
CI: Confidence interval; PPV: Positive predictive value;
* Complete data results (1,050 subjects)
1. Zeisler, H., et al. (2016). N Engl J Med 374(1), 13-22
T畛 s畛 sFlt-1/PlGF h畛 tr畛 x叩c 畛nh TSG trong
4 tu畉n 畛 thai ph畛 nghi ng畛 TSG
Gi炭p qu畉n l箪 t畛t th畛i gian b畛nh nh但n
Ti棚n l動畛ng ng畉n h畉n TSG / SG / HELLP
X叩c 畛nh trong 4 tu畉n
(Validation cohort, n = 550)1*
sFlt-1/PlGF ratio cut-off 38
PPV (95% CI) 36.7% (28.4-45.7)
Sensitivity (95% CI) 66.2% (54.0-77.0)
Specificity (95% CI) 83.1% (79.486.3)
18. L畛i 鱈ch kinh t畉 y t畉 nh畛
ch畉n o叩n s畛m TSG
Ph動董ng ph叩p v ti棚u chu畉n chm s坦c
M担 h狸nh t叩c 畛ng ng但n s叩ch, d湛ng m畛t ph畉n m畛m ph但n t鱈ch so
s叩nh hai m担 h狸nh th畛 nghi畛m TSG:
Th畛c hnh chu畉n 畛 UK/German bao g畛m XN m叩u, n動畛c
ti畛u, o huy畉t 叩p v si棚u 但m Doppler MTC
Th畛c hnh chu畉n 畛 UK/German + o PIGF, sFlt-1 (Elecsys速
platform) t畛 tu畉n 20
C畉 NICE v DGGG guidelines y棚u c畉u c叩c b叩c s挑 ph但n t畉ng
b畛nh nh但n v畛 nguy c董 cao 畛i v畛i TSG khi x叩c 畛nh th畛i k畛
mang thai c畛a b畛nh nh但n v 叩nh gi叩 t狸nh tr畉ng s畛c kho畉
Thai ph畛 c坦 nguy c董 cao TSG s畉 動畛c theo d探i th動畛ng xuy棚n
h董n cho 畉n khi ch畉n o叩n 動畛c TSG b畉t 畉u t畛 tu畉n 20
19. 畛ng d畛ng XN m畛i ny 畛 Anh, h畛 th畛ng chm s坦c
s畛c kh畛e qu畛c gia ti畉t ki畛m 730 tri畛u B畉ng h畉ng
nm v 畛c ti畉t ki畛m 畉n EUR 436 tri畛u/ nm
Budget impact of novel PE test in the UK
Budget impact of novel PE test in
Germany
Hadker N, Garg S, et al. (2010). J Med Econ 13(4):728-37; Hadker N, Garg S, et al. (2013). Hypertens Pregnancy 32(2): 105119
20. 叩nh gi叩 kinh t畉 c畛a t畛 s畛 sFlt-1/PlGF
tr棚n TSG
A UK NHS payer perspective
NHS, National Health Service; PlGF, placental growth factor;
sFlt-1, soluble fms-like tyrosine kinase-1
Ultrasound Obstet Gynecol 2016
叩nh gi叩 t叩c 畛ng
kinh t畉 c畛a t畛 s畛
sFlt-1/PlGF tr棚n thai
ph畛 nghi ng畛 TSG
畛 Anh
21. D畛 ph嘆ng c畉p 3
i畛u tr畛 TSG n畉ng hi畛u qu畉 tr叩nh c叩c
bi畉n ch畛ng cho m畉 v thai